104 related articles for article (PubMed ID: 15603307)
1. Biological optimization of the dose in stereotactic radiotherapy of brain tumors.
De Santis M; Balducci M; Simili A; Frascino V; Giammarino D
Rays; 2004; 29(3):339-42. PubMed ID: 15603307
[TBL] [Abstract][Full Text] [Related]
2. Hypofractionation regimens for stereotactic radiotherapy for large brain tumors.
Yuan J; Wang JZ; Lo S; Grecula JC; Ammirati M; Montebello JF; Zhang H; Gupta N; Yuh WT; Mayr NA
Int J Radiat Oncol Biol Phys; 2008 Oct; 72(2):390-7. PubMed ID: 18374501
[TBL] [Abstract][Full Text] [Related]
3. Role of stereotactic radiosurgery and fractionated stereotactic radiotherapy in pediatric brain tumors.
Lo SS; Fakiris AJ; Abdulrahman R; Henderson MA; Chang EL; Suh JH; Timmerman RD
Expert Rev Neurother; 2008 Jan; 8(1):121-32. PubMed ID: 18088205
[TBL] [Abstract][Full Text] [Related]
4. The American Society for Therapeutic Radiology and Oncology (ASTRO) evidence-based review of the role of radiosurgery for malignant glioma.
Tsao MN; Mehta MP; Whelan TJ; Morris DE; Hayman JA; Flickinger JC; Mills M; Rogers CL; Souhami L
Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):47-55. PubMed ID: 16111571
[TBL] [Abstract][Full Text] [Related]
5. Universal survival curve and single fraction equivalent dose: useful tools in understanding potency of ablative radiotherapy.
Park C; Papiez L; Zhang S; Story M; Timmerman RD
Int J Radiat Oncol Biol Phys; 2008 Mar; 70(3):847-52. PubMed ID: 18262098
[TBL] [Abstract][Full Text] [Related]
6. Reirradiation tolerance of the human brain.
Mayer R; Sminia P
Int J Radiat Oncol Biol Phys; 2008 Apr; 70(5):1350-60. PubMed ID: 18037587
[TBL] [Abstract][Full Text] [Related]
7. Hypofractionated stereotactic radiotherapy for brain metastases--results from three different dose concepts.
Fahrig A; Ganslandt O; Lambrecht U; Grabenbauer G; Kleinert G; Sauer R; Hamm K
Strahlenther Onkol; 2007 Nov; 183(11):625-30. PubMed ID: 17960338
[TBL] [Abstract][Full Text] [Related]
8. Comparison of (125)I stereotactic brachytherapy and LINAC radiosurgery modalities based on physical dose distribution and radiobiological efficacy.
Viola A; Major T; Julow J
Radiat Res; 2006 Jun; 165(6):695-702. PubMed ID: 16802870
[TBL] [Abstract][Full Text] [Related]
9. Hypofractionated stereotactic radiotherapy using intensity-modulated radiotherapy in patients with one or two brain metastases.
Narayana A; Chang J; Yenice K; Chan K; Lymberis S; Brennan C; Gutin PH
Stereotact Funct Neurosurg; 2007; 85(2-3):82-7. PubMed ID: 17167236
[TBL] [Abstract][Full Text] [Related]
10. The linear-quadratic model is inappropriate to model high dose per fraction effects in radiosurgery.
Kirkpatrick JP; Meyer JJ; Marks LB
Semin Radiat Oncol; 2008 Oct; 18(4):240-3. PubMed ID: 18725110
[TBL] [Abstract][Full Text] [Related]
11. Role of stereotactic radiosurgery and fractionated stereotactic radiotherapy in the management of intracranial ependymoma.
Lo SS; Chang EL; Sloan AE
Expert Rev Neurother; 2006 Apr; 6(4):501-7. PubMed ID: 16623649
[TBL] [Abstract][Full Text] [Related]
12. Hypofractionated stereotactic radiotherapy and radiosurgery for the treatment of patients with radioresistant brain metastases.
Scorsetti M; Facoetti A; Navarria P; Bignardi M; De Santis M; Ninone SA; Lattuada P; Urso G; Vigorito S; Mancosu P; Del Vecchio M
Anticancer Res; 2009 Oct; 29(10):4259-63. PubMed ID: 19846983
[TBL] [Abstract][Full Text] [Related]
13. An estimation of radiobiologic parameters from clinical outcomes for radiation treatment planning of brain tumor.
Qi XS; Schultz CJ; Li XA
Int J Radiat Oncol Biol Phys; 2006 Apr; 64(5):1570-80. PubMed ID: 16580506
[TBL] [Abstract][Full Text] [Related]
14. [Recent management of metastatic brain tumors].
Abe M; Tabuchi K
No To Shinkei; 2005 Dec; 57(12):1058-66. PubMed ID: 16375191
[No Abstract] [Full Text] [Related]
15. Biological optimization of the dose in pancreatic cancer.
Mattiucci GC; D'Agostino G; De Bari B; Mangiacotti MG; Smaniotto D; Trodella L
Rays; 2004; 29(3):301-8. PubMed ID: 15603302
[TBL] [Abstract][Full Text] [Related]
16. Current developments in radiotherapy for paediatric brain tumours.
Taylor RE
Eur J Paediatr Neurol; 2006 Jul; 10(4):167-75. PubMed ID: 16954052
[TBL] [Abstract][Full Text] [Related]
17. Less common indications for stereotactic radiosurgery or fractionated radiotherapy for patients with benign brain tumors.
Knisely JP; Linskey ME
Neurosurg Clin N Am; 2006 Apr; 17(2):149-67, vii. PubMed ID: 16793507
[TBL] [Abstract][Full Text] [Related]
18. Phase II trial of hypofractionated stereotactic radiotherapy for brain metastases: results and toxicity.
Ernst-Stecken A; Ganslandt O; Lambrecht U; Sauer R; Grabenbauer G
Radiother Oncol; 2006 Oct; 81(1):18-24. PubMed ID: 16978720
[TBL] [Abstract][Full Text] [Related]
19. The American Society for Therapeutic Radiology and Oncology (ASTRO) evidence-based review of the role of radiosurgery for brain metastases.
Mehta MP; Tsao MN; Whelan TJ; Morris DE; Hayman JA; Flickinger JC; Mills M; Rogers CL; Souhami L
Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):37-46. PubMed ID: 16111570
[TBL] [Abstract][Full Text] [Related]
20. Hypofractionated conformal stereotactic radiotherapy alone or in combination with whole-brain radiotherapy in patients with cerebral metastases.
Lindvall P; Bergström P; Löfroth PO; Henriksson R; Bergenheim AT
Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1460-6. PubMed ID: 15817351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
